Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P06889 (
Mol
)
630,302
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Evidence is presented here that demonstrates the presence of NP185 (AP3) in neuronal cells, specifically within syn-aptic terminals of the central nervous system and in the peripheral nervous system, particularly in the neuro-muscular junction of adult chicken muscle. Biochemical results obtained in our laboratories indicate that NP185 is associated with brain synaptic vesicles, with clathrin-coated vesicles, and with the synaptosomal plasma membrane. Also, NP185 binds to tubulin and clathrin light chains and the binding is regulated by phosphorylation (Su et al., 1991). Based on these properties and the data reported here, we advance the postulate that NP185 fulfills multiple functions in synaptic terminals. One function is that of a plasma membrane docking or channel protein, another of a signaling molecule for brain vesicles to reach the synaptic terminal region, and a third is that of a recycling molecule by binding to protein components on the lipid bilayer of the synaptic plasma membrane during the process of endocytosis. In support of these premises, a thorough study of NP185 using the developing chick brain, adult mouse brain, and chicken straited muscle was begun by temporally and spatially mapping the expression and localization of NP185 in evolving and mature nerve endings. To achieve these objectives, monoclonal antibodies to NP185 were used for immunocytochemistry in tissue sections of chicken and mouse cerebella. The distribution of NP185 was compared with those of other cytoskeletal and cytoplasmic proteins of axons and synapses, namely synaptophysin, vimentin, neurofilament NF68, and the intermediate filaments of glial cells (
GFAP
). The data indicate that expression of NP185 temporally coincides with synaptogenesis, and that the distribution of this protein is specific for synaptic terminal buttons of the CNS and the PNS.
Mol
Neurobiol
PMID:Neuronal protein NP185 is developmentally regulated, initially expressed during synaptogenesis, and localized in synaptic terminals. 147 76
Primary cultures of rat glial cells were established from newborn rat forebrains. A mixed population of oligodendrocytes and astrocytes was obtained, as confirmed by indirect immunofluorescence staining with specific markers for each cell type. Receptors were measured 3 weeks after primary culture in glial cells cultured in the presence or not of 50 nM estradiol and we have identified progesterone, glucocorticoid, estrogen, and androgen receptors (PR, GR, ER and AR), but only PR was inducible by the estrogen treatment. This estrogen-induction of PR was more dramatic in glial cells derived from female offsprings than from males, as measured by binding studies and by immunohistochemical techniques with the KC 146 anti-PR monoclonal antibody. The antiestrogen tamoxifen inhibited the estrogen induction, but had no effect by itself on PR concentration. Specific binding sites for PR, GR, ER and AR were measured by whole cell assays after labeling cells with, respectively, [3H]R5020, [3H]dexamethasone, [3H]OH-tamoxifen or [3H]R1881. PR and GR were also analyzed by ultracentrifugation and after exposure of cells to agonists, both receptors were recovered from cytosol as a 9S form, and from the nuclear high-salt, tungstate ions-containing fraction as a 4-6S form. In contrast, when the antiprogestin- and antiglucocorticosteroid RU486 was used as a ligand, a non-activated 8.5S receptor complex was found for both receptors in this nuclear fraction. The 8.5S complex of the GR was further analyzed in the presence of specific antibodies and, in addition to GR, the presence of the heat shock protein hsp90 and of a 59 kDa protein was found. During primary culture, the effects of progesterone (P) and estradiol (E2) were tested on glial cell multiplication, morphology and differentiation. Cell growth was inhibited by P and stimulated by E2. Both hormones induced dramatic morphologic changes in oligodendrocytes and astrocytes and increased synthesis of the myelin basic protein in oligodendrocytes and of the
glial fibrillary acidic protein
in astrocytes.
J Steroid Biochem
Mol
Biol 1992 Mar
PMID:Demonstration of steroid hormone receptors and steroid action in primary cultures of rat glial cells. 156 33
Entorhinal cortex lesions (ECL) that damage the perforant path to the hippocampus induce rapid increases of apolipoprotein E (apo E) mRNA in the hippocampus. Apo E mRNA was localized in astrocytes by in situ hybridization in combination with immunocytochemistry for
glial fibrillary acidic protein
(
GFAP
). Unilateral ECL also increased hippocampal
GFAP
mRNA, with increases preceding those of apo E mRNA. The apo E mRNA and
GFAP
mRNA responses were transiently bilateral in non-denervated zones. The timing of response in apo E mRNA to deafferentation supports suggestions that apo E has roles in membrane remodelling during responses to neuron injury.
Brain Res
Mol
Brain Res 1991 Sep
PMID:Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. 166 18
Evidence is given for altered gene expression in the hippocampus in response to entorhinal cortex lesioning. Three RNA markers encoding
glial fibrillary acidic protein
, apolipoprotein E and alpha-tubulin were isolated from a rat hippocampal cDNA library by differential screening with cDNA probes from entorhinal cortex lesioned and control rat hippocampus RNA. By Northern blot analysis, mRNA for apolipoprotein E and alpha-tubulin increased to peak around 6 days after the lesion and returned to near control level at 30 days. The increased synthesis of both mRNAs coincides with the acute phase of synaptogenesis, protein synthesis, and polyribosomes accumulation in the deafferented hippocampal area.
Brain Res
Mol
Brain Res 1991 Feb
PMID:Cloning of hippocampal poly(A) RNA sequences that increase after entorhinal cortex lesion in adult rat. 167 53
Astrogliosis is a prominent feature in the CNS of the dysmyelinating mutant, jimpy. In the following study the expression of the glial markers,
glial fibrillary acidic protein
(
GFAP
) and glutamine synthetase (GS) mRNAs were examined the cerebra of normal and jimpy mice. The relative abundance of
GFAP
and GS mRNAs increased rapidly in the CNS of normal mice during the first two postnatal weeks. During the third week the content of
GFAP
and GS mRNA remained constant. The pattern of developmental accumulation of these transcripts in jimpy animals was distinctly different. Levels of
GFAP
transcripts in 6- and 10-day-old jimpy animals were essentially the same as controls. In 14-day-old animals, however, the content of
GFAP
mRNA in jimpy had increased dramatically, and was 3-fold greater than that found in normal animals. The levels of
GFAP
message remained significantly elevated above control values for the life of the animals, approximately 22-24 days. In contrast, no significant difference in GS mRNA content was detected between control and jimpy brain tissue. The results of this study indicated that increased accumulation of
GFAP
mRNA was significant component of reactive gliosis and that the mechanisms responsible for the induction of
GFAP
were dissociated from those that regulate GS expression.
Brain Res
Mol
Brain Res 1991 Mar
PMID:Developmental expression of glial fibrillary acidic protein and glutamine synthetase mRNAs in normal and jimpy mice. 167 13
Developmental regulation in mRNAs of three brain proteins has been investigated by Northern blot evaluation in C57BL/6 mice. The mRNAs of two cytoskeletal components,
glial fibrillary acidic protein
(
GFAP
) and beta actin, varied significantly, and differently, during brain development (0-56 days postnatal). The beta actin mRNAs peaked at day 1 after a slight increase, then dropped rapidly during the first 15 days postnatal, and thereafter remained at a level which was strictly maintained throughout development and adulthood. Conversely, the
GFAP
mRNAs increased during the first two weeks after birth (astroglial proliferation), and then slightly declined until the adult stage (astroglial cell differentiation). The prion protein (PrP) mRNAs were detectable as soon as birth, and increased 4-fold during brain maturation. Then, during the adult life, the
GFAP
and PrP mRNAs did not change markedly. Nevertheless, slight but significant increases in the mRNA levels of both
GFAP
and PrP were observed at older stages (360 days). These results are analysed in the light of the implications of PrP and
GFAP
in scrapie infection models.
Brain Res
Mol
Brain Res 1991 Jul
PMID:Regulation of the glial fibrillary acidic protein, beta actin and prion protein mRNAs during brain development in mouse. 168 6
Fifty-one non-neoplastic human pituitary glands, including examples with Crooke's hyalinization or amyloidosis, were examined by an immunoperoxidase method using antibodies to keratin, vimentin, neurofilaments (NFs),
glial fibrillary acidic protein
(
GFAP
), desmin, actin, S-100 protein and a variety of pituitary hormones. It was confirmed that most of the epithelial cells in the pituitary gland express keratin immunoreactivity. These cells included endocrine cells in the anterior lobe, endocrine cells and squamous metaplastic cells in the pars tuberalis, columnar and ciliated epithelia forming follicular structures and salivary-type epithelium in the pars intermedia, and anterior lobe cells infiltrating the posterior lobe. This study also demonstrated that keratin and NFs may be co-expressed in endocrine cells in the pituitary anterior lobe, that keratin, vimentin and
GFAP
may be co-expressed in the epithelial cells forming cyst-like follicle in the pars intermedia, and that vimentin and
GFAP
may be co-expressed in folliculo-stellate cells and pituicytes. In addition, the
GFAP
and S-100 protein-negative high columnar epithelium in the pars intermedia tended to be positive for adrenocorticotropic hormone and melanocyte stimulating hormone, while the low columnar epithelium with the co-expression of
GFAP
and S-100 protein was negative for pituitary hormones.
Virchows Arch B Cell Pathol Incl
Mol
Pathol 1990
PMID:Intermediate filament expression in non-neoplastic pituitary cells. 169 52
Seventy-five formalin-fixed and 18 alcohol-fixed pituitary adenomas were studied immunohistochemically using antibodies to keratin, vimentin, neurofilaments (NFs),
glial fibrillary acidic protein
, desmin, actin, S-100 protein and a variety of pituitary hormones. The pituitary adenoma cells were positive for keratin, vimentin and NFs (68 kDa and 160 kDa) and in a few instances there was co-expression of these three types of intermediate filaments (IMFs). The pattern of keratin-specific staining showed diffuse cytoplasmic or patchy paranuclear reactivity and of NF- or vimentin-specific staining showed fibrillar or patchy paranuclear reactivity. The patchy staining seemed to decorate the fibrous body. There was no correlation between the distribution of IMFs and pituitary hormones in pituitary adenomas except that melanocyte-stimulating-hormone-positive reactivity was limited to the NF-positive adenomas. The pattern of IMF staining did not depend on hormone production in adenomas.
Virchows Arch B Cell Pathol Incl
Mol
Pathol 1990
PMID:Intermediate filament expression in pituitary adenomas. 169 53
To define at the molecular biological level the effects of thyroid hormone on brain development we have examined cDNA clones of brain mRNAs and identified several whose expression is altered in hypothyroid animals during the neonatal period. Clones were identified with probes prepared by subtractive or differential hybridization, and those corresponding to mRNAs altered in hypothyroidism were further studied by Northern blot analysis. Using RNA prepared from whole brains, no effect of hypothyroidism was found on the expression of the astroglial gene coding for
glial fibrillary acidic protein
. Among genes of neuronal expression, no significant alterations were found in the steady state levels of mRNAs coding for neuron-specific enolase, microtubule-associated protein-2, Tau, or nerve growth factor. N-CAM mRNA increased slightly in hypothyroid brains. In contrast a 2- to 3-fold decrease was found in the mRNA coding for a novel neuronal gene, RC3. This is the first neuronal gene known to be significantly altered at the mRNA level by thyroid hormone deprivation. The abundance of the mRNAs for the major myelin proteins proteolipid protein, myelin basic protein, and myelin-associated glycoprotein, expressed by oligodendrocytes, were also decreased in hypothyroid brains. Developmental studies on RC3 and myelin-associated glycoprotein expression indicated that the corresponding mRNAs accumulate in the brain of normal rats during the first 15-20 days of neonatal life. A similar accumulation occurred in hypothyroid brains, but at much reduced levels. The results demonstrate that thyroid hormone controls the steady state levels of particular mRNAs during brain development.
Mol
Endocrinol 1991 Feb
PMID:Effects of neonatal hypothyroidism on rat brain gene expression. 171 32
We have investigated the phylogenetic distribution of the
glial fibrillary acidic protein
(
GFAP
) in lens epithelial cells (LEC) of various mouse species within the genus Mus. We have shown that lens
GFAP
is expressed in mice of the Mus musculus complex and in Mus spicilegus and Mus macedonicus species (L.
GFAP
(+) phenotype) while it is absent in Mus spretus, Mus caroli and Mus cooki species (L.
GFAP
(-) phenotype). Our results argue in favour of one of the phenograms illustrating the probable phylogenetic relationships between these species in the genus Mus. In animals where lens
GFAP
was immunodetected, Northern blots of lens RNA extracts hybridized with a mouse
GFAP
cDNA probe, revealed a single 2.7 kb band. Comparative Northern blot analysis of lens tissue from L.
GFAP
(+) mice or of brain tissue from L.
GFAP
(+) or L.
GFAP
(-) mice did not show any size heterogeneity of the
GFAP
mRNA. The pattern of the
GFAP
immunostaining of astroglial cells in brain was identical in both L.
GFAP
phenotypes. Analysis of interspecific crosses showed that the L.
GFAP
(+) character is transmitted in a dominant fashion and seems to be linked to the Mus musculus Gfap gene. In this study we have also confirmed the localization of the mouse Gfap gene on chromosome 11.
Brain Res
Mol
Brain Res 1991 May
PMID:Recent evolutionary origin of the expression of the glial fibrillary acidic protein (GFAP) in lens epithelial cells. A molecular and genetic analysis of various mouse species. 171 88
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>